CIK: 0001952142
Total reported value
$522.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 8.52% | — | +28.26% | |
| 2 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 8.43% | -1.55% | -36.97% | |
| 3 | IMVT | Immunovant INC | Stock-Other | 7.85% | — | +15.35% | |
| 4 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 7.25% | — | -30.66% | |
| 5 | ✓ | Merus N V | Stock-Other | 5.02% | — | -9.47% | |
| 6 | ACLXGBX | Arcellx INC | Stock-Other | 4.55% | -3.72% | EXIT | |
| 7 | AM6 | Amicus Therapeutics INC | Stock-Other | 4.36% | — | -23.22% | |
| 8 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 3.38% | — | — | |
| 9 | APLT | Applied Therapeutics INC | Stock-Other | 3.03% | — | +9.63% | |
| 10 | MRK | Merck & Co. INC. | Stock-Healthcare | 2.98% | — | — | |
| 11 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 2.78% | — | — | |
| 12 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 2.74% | — | +96.82% | |
| 13 | AUTL | Autolus Therapeutics PLC | Stock-Other | 2.72% | — | -17.20% | |
| 14 | CABA | Cabaletta Bio INC | Stock-Other | 2.59% | — | -21.66% | |
| 15 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 2.55% | — | -36.54% | |
| 16 | BHVN | Biohaven Ltd. | Stock-Other | 2.38% | +2.58% | NEW | |
| 17 | VTGN | Vistagen Therapeutics INC | Stock-Other | 1.72% | — | — | |
| 18 | ✓ | Immatics NV | Stock-Other | 1.71% | -1.10% | EXIT | |
| 19 | DNLI | Denali Therapeutics INC | Stock-Other | 1.71% | — | — | |
| 20 | INSM | Insmed INC | Stock-Healthcare | 1.71% | — | -68.07% | |
| 21 | CLDX | Celldex Therapeutics INC | Stock-Other | 1.57% | +1.54% | NEW | |
| 22 | LRMR | Larimar Therapeutics INC | Stock-Other | 1.50% | — | -4.93% | |
| 23 | TCRX | Tscan Therapeutics INC | Stock-Other | 1.45% | — | — | |
| 24 | EWTX | Edgewise Therapeutics INC | Stock-Other | 1.43% | — | — | |
| 25 | CRBP | Corbus Pharmaceuticals Holdi | Stock-Other | 1.35% | — | — | |
| 26 | FULC | Fulcrum Therapeutics INC | Stock-Other | 1.27% | — | +71.08% | |
| 27 | NRIX | Nurix Therapeutics INC | Stock-Other | 1.25% | +0.94% | NEW | |
| 28 | PYXS | Pyxis Oncology INC | Stock-Other | 1.17% | — | -32.97% | |
| 29 | JANX | Janux Therapeutics INC | Stock-Other | 1.14% | — | -23.59% | |
| 30 | IDYA | Ideaya Biosciences INC | Stock-Other | 1.05% | -0.96% | EXIT | |
| 31 | SYRE | Spyre Therapeutics INC | Stock-Other | 1.04% | +1.44% | +141.68% | |
| 32 | CATX | Perspective Therapeutics INC | Stock-Other | 1.01% | — | — | |
| 33 | JSPR | Jasper Therapeutics INC | Stock-Other | 0.96% | — | +11.27% | |
| 34 | BDTX | Black Diamond Therapeutics I | Stock-Other | 0.92% | — | — | |
| 35 | VIGL | Vigil Neuroscience INC | Stock-Other | 0.88% | — | — | |
| 36 | NGNE | Neurogene INC | Stock-Other | 0.84% | — | — | |
| 37 | SLN | Silence Therapeutics Plc-adr | Stock-Other | 0.70% | — | — | |
| 38 | TARA | Protara Therapeutic INC | Stock-Other | 0.60% | — | +283.91% | |
| 39 | ✓ | Helix Acquisition CORP Ii | Stock-Other | 0.60% | — | — | |
| 40 | SRZN | Surrozen INC | Stock-Other | 0.46% | — | — | |
| 41 | ✓ | Stock-Other | 0.44% | — | — | ||
| 42 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.36% | +2.41% | +8.80% |